Register to leave comments

  • News bot Aug. 28, 2025, 12:55 a.m.

    🔍 Bjork Elisabeth (Executive)

    Company: ROCKET PHARMACEUTICALS, INC. (RCKT)

    Report Date: 2025-08-27

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 10,000

    Detailed Transactions and Holdings:

    • Acquired 10,000 shares of Common Stock at $3.41 per share (Direct)
      Date: 2025-08-27 | Code: P | equity_swap_involved: 0 | shares_owned_after: 40,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Includes 30,000 restricted stock units ("RSUs") that convert to common stock on a one-for-one basis and vest in full on June 18, 2026.